Global prevalence and characteristics of infections and clinical outcomes in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium
Zhujun Cao,Florence Wong,Ashok K Choudhury,Patrick S Kamath,Mark Topazian,Aldo Torre,Peter C Hayes,Jacob George,Ramazan Idilman,Wai-Kay Seto,Hailemichael Desalegn,Mario Reis Alvares-da-Silva,Brian J Bush,Leroy R Thacker,Qing Xie,Jasmohan S Bajaj,CLEARED Consortium,Shiva Kumar,Adrián Gadano,Sebastián Marciano,Fiona Tudehope,Alexander Prudence,Robert Gibson,Amany Zekry,Adam Doyle,Hooi Ling Si,Yu Sung Kim,Cameron Gofton,Stephen Riordan,Gerry MacQuillan,Hala Al-Tamimi,Matheus Michalczuk,Alberto Farias,Patricia Zitelli,Gustavo Pereira,Livia Victor,Chinmay Bera,Nabiha Faisal,Monica Dahiya,Puneeta Tandon,Marie Jeanne Lohoues,Ponan Claude Regis Lah,Carlos Benítez,Marco Arrese,Jing Guan,Yongchao Xian,Chuanwu Zhu,Yingling Wang,Man Su,Minghua Su,Xinrui Wang,Yanhang Gao,Feng Peng,Yongfang Jiang,Caiyan Zhao,Wei Wang,Dedong Yin,Lei Wang,Mingqin Lu,Yijing Cai,Feng Guo,Xiaozhong Wang,Ningping Zhang,Wanqin Zhang,Fuchen Dong,Hai Li,Jing Liu,Xin Zheng,Hong Tang,Libo Yan,Bin Xu,Linlin Wei,Zhen Xu,Zhiliang Gao,Haibing Gao,Minghua Lin,Qunfang Rao,Xiaoping Wu,Beiling Li,Jinjun Chen,Chenghai Liu,Yanyun Zhang,Huan Deng,Peng Hu,Jian Wang,Jie Li,Dominik Bettinger,Michael Schultheiß,Hibat Allah Belimi,Nabil Debzi,Alaa Mostafa,Yasser Fouad,Henok Fisseha,Suresh Vasan Venkatachalapathy,Aloysious D Aravinthan,Neil Rajoriya,Rosemary Faulkes,Damien Leith,Ewan Forrest,Adebayo Danielle,James Kennedy,Diana Yung,Alexandra Alexopoulou,Iliana Mani,James Fung,Helena Katchman,Liane Rabinowich,Ajay Jhaveri,Aabha Nagral,Anand Kulkarni,Mithun Sharma,Shiv K Sarin,Ashish Goel,C E Eapen,Ajay Duseja,Akash Gandotra,Anoop Saraya,Jatin Yegurla,Dinesh Jothimani,Mohammad Rela,Anil Arora,Ashish Kumar,Akash Roy,R K Dhiman,A C Anand,Dibyalochan Praharaj,Araceli Bravo Cabrera,Sarai Gonzalez Hueso,José Luis Pérez Hérnandez,Oscar Morales Gutierrez,Abraham Ramos-Pineda,Godolfino Miranda Zazueta,Mauricio Castillo Barradas,Lilian Torres Made,Rene Male Velazquez,Francisco Félix-Tellez,José Antonio Velarde-Ruiz Velasco,Jacqueline Cordova-Gallardo,Ruveena Rajaram,Nik Arsyad Nik Muhamad Afendi,David P Nyam,Edith N Okeke,Dalia Allam,Yashwi Haresh Kumar Patwa,Hiang Keat Tan,Liou Wei Lun,Wei Ling Danielle Ho,Yu Jun Wong,Kessarin Thanapirom,Tongluk Teerasarntipan,Busra Haktaniyan,Feyza Gunduz,Rahmi Aslan,Abdullah Emre Yildirim,Sezgin Barutcu,Alper Uysal,Zeki Karasu,Enver Ucbilek,Tolga Kosay,Dinç Dinçer,Haydar Adanır,Somaya Albhaisi,Mohammad Amin Fallahadeh,Sumeet Asrani,K Rajender Reddy,Jawaid Shaw,Hugo Vargas,Natalia Filipek,Scott W Biggins,Paul Thuluvath,Somya Sheshadri,Kara Wegermann,Matthew Kappus,Andrew Keaveny,Andres Rojo,Ricardo Cabello Negrillo,Elizabeth Verna
DOI: https://doi.org/10.1016/S2468-1253(24)00224-3
2024-09-04
Abstract:Background: Infections have a poor prognosis in inpatients with cirrhosis. We aimed to determine regional variations in infections and their association with clinical outcomes in a global cohort of inpatients with cirrhosis. Methods: In this prospective cohort study initiated by the CLEARED Consortium, we enrolled adults (aged >18 years) with cirrhosis who were non-electively admitted to 98 hospitals from 26 countries or regions across six continents between Nov 5, 2021, and Dec 10, 2022. Data at admission, during hospitalisation, and for 30 days after discharge were collected through patient reports and chart reviews. Collected data included demographics; country and country income level per World Bank classifications (high-income countries [HICs], upper-middle-income countries [UMICs], and low-income or lower-middle-income countries [L-LMICs]); comorbidities; characteristics related to cirrhosis and the infections, including types, culture results, and drug resistance profile; antibiotic use; and disease course while hospitalised and for 30 days post-discharge. The primary outcome was in-hospital death or hospice referral in those with versus those without an admission infection (defined by the presence of infection on or within 48 h of admission). Multivariable log-binomial regression for in-hospital death or hospice referral was performed to identify risk factors. Findings: Of 4550 patients screened, 4238 patients (mean age 56·1 years [SD 13·3]; 2711 [64·0%] male and 1527 [36·0%] female) with complete data were enrolled. 1351 (31·9%) had admission infections. A higher proportion of patients in L-LMICs had infections (318 [41·7%] of 762 vs 444 [58·3%] without infection) than in UMICs (588 [30·6%] of 1922 vs 1334 [69·4%]) or HICs (445 [28·6%] of 1554 vs 1109 [71·4%]). Patients with admission infections had worse severity of cirrhosis and were more likely to have had an infection or been hospitalised in the preceding 6 months. The most common specific infection types were spontaneous bacterial peritonitis (391 [28·9%] of 1351), pneumonia (233 [17·2%]), and urinary tract infections (193 [14·3%]). 549 (40·6%) patients were culture-positive for bacterial or fungal infections, with the lowest culture-positive rates in Africa and mainland China. Most of the isolated organisms were Gram-negative (345 [63%] of 549), then Gram-positive (157 [29%]), and then fungi or mixed (47 [9%]), with Escherichia coli, Klebsiella pneumoniae, and Enterococcus spp being the top three isolated pathogens. The overall rate of drug resistance was 40% (220 of 549 with positive cultures), being highest in UMICs. The most used empirical antimicrobials were third-generation cephalosporins (453 [37%] of 1241), followed by the broad-spectrum β-lactams and β-lactamase inhibitors (289 [23%]). De-escalation was observed in 62 (20%) of 304 patients who had their antibiotics changed. Patients with versus without admission infections had a higher rate of in-hospital death or hospice transfer (299 [22·1%] of 1351 vs 232 [8·0%] of 2887; p<0·0001), a result replicated in multivariable analysis (adjusted risk ratio 1·75 [95% CI 1·42-2·06]; p<0·0001). Older age, self-reported female gender, not being in a HIC, lactulose use, and higher MELD-Na score were also associated with in-hospital death or hospice transfer on multivariable analysis. Interpretation: In the CLEARED Consortium cohort of inpatients with cirrhosis, the rates and types of infections, causative organisms, and culture-positivity varied substantially across regions, and infections were associated with a higher mortality risk. Culture positivity, which guides appropriate antibiotic use, was low. Taking a global perspective, considering regional variations in infections, drug resistance, and resources, could help to alleviate disparities in burden and outcomes. Funding: US Department of Veterans Affairs, the Richmond Institute for Veterans Research, the National Natural Science Foundation of China, Shanghai Rising-Star Program, the National Council for Scientific and Technological Development of Brazil, and Shanghai Municipal Key Clinical Specialty.